Read more at Financial Times.
US drug ‘gatekeepers’ face FTC antitrust lawsuit over insulin prices
Date: |
Topics
-
The Wall Street Journal - Business
FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.2 hours ago -
MarketWatch - Business
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’
Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, regulator alleges.1 hour ago -
CNBC - Business
FTC sues drug middlemen for allegedly inflating insulin prices
The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts.27 minutes ago -
The New York Times - Health
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.3 hours ago -
CBS News - Top stories
Drug middlemen illegally drive up the cost of insulin, FTC says
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.14 minutes ago -
NBC News - Top stories
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.1 hour ago -
The Wall Street Journal - Business
The Price War in Weight-Loss Drugs Is Here
Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price tags of over $1,000 a month.9 hours ago -
Inc. - Business
FTC Chair Lina Khan Says Antitrust Regulations Help Small Businesses Too
At the Fast Company Innovation Festival, Khan said that monopolies aren't just a consumer rights issue.6 hours ago -
Financial Times - World
Michael Jackson estate says accuser is trying to extract $213mn
The King of Pop’s legacy has generated $3bn since his death but remains overshadowed by child sex abuse claims1 hour ago
More from Financial Times
-
Financial Times - Business
Israel kills elite Hizbollah commanders in Beirut strike, IDF says
Air strike on Ibrahim Aqil and Radwan Force follows a wave of deadly blasts in Lebanon1 hour ago - Israel -
Financial Times - Business
Israel challenges ICC prosecutor’s call to arrest its leaders
Officials say court lacks jurisdiction in case against Benjamin Netanyahu and defence minister5 hours ago - Israel -
Financial Times - Business
‘A nightmare on repeat’: Lebanese process sabotaged device attacks
Shocked citizens, extreme injuries and a powerful militant group in disarray: the impact of thousands of pager and walkie-talkie blasts8 hours ago -
Financial Times - Business
Did central banks get the inflation crisis right?
Policymakers are lowering rates and signalling new confidence that a ‘soft landing’ is possible. But few are ready to declare victory1 hour ago -
Financial Times - Business
Has Powell just triggered a dash out of cash?
Analysts have long predicted some $6tn held in US money market funds might move into riskier assets like equities2 hours ago